DK
David Kurtz
Also known as: David Matthew Kurtz
Stanford University, Mayo Clinic College of Medicine, California Institute of Technology
Research areas: Medicine · Hematology · Lymphoma Diagnosis and Treatment · Cancer Genomics and Diagnostics · Chronic Lymphocytic Leukemia Research
0000-0002-6382-4651
Employment
-
Stanford University Assistant Professor2021 - Present
-
Stanford University School of Medicine Instructor2018 - 2021
-
Stanford University School of Medicine Hematology & Oncology Fellow2009 - 2018
Education
- 2011 - 2018
-
Mayo Clinic College of Medicine MD2005 - 2009
- 2001 - 2005
Projects & Funding
-
Molecular Characterization and Personalized Approaches to Non-Hodgkin Lymphoma from Circulating Tumor DNA National Cancer Institute2019 - 2024
Publications (95)
- Data from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors Save
- Supplementary Methods & Figures S1-S5 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors Save
- Supplementary Tables S1-S15 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors Save
- Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma Save
- Data from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Figures S1-S8 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Table S1-S10 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Genetic alteration of class I HLA in cutaneous T-cell lymphoma Save
- Data from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors Save
- Supplementary Methods & Figures S1-S5 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors Save
- Supplementary Methods & Figures S1-S5 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors Save
- Supplementary Tables S1-S15 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors Save
- Supplementary Tables S1-S15 from Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors Save
- Specificity of Immunoglobulin High-Throughput Sequencing Minimal Residual Disease Monitoring in Non-Hodgkin Lymphomas. Save
- Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Save
- Genomic abnormalities involving class I HLA are common in advanced cutaneous T-cell lymphoma Save
- Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab Vedotin Save
- Cell-free DNA in large B-cell lymphoma: MRD and beyond Save
- Data from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors Save